Clinical TrialsSearch results
Number of results: 66707
Recruiting
- The study of the treatment of Male Menopause with MSC-CM
- the Treatment for Male Menopause
- Hirayama Takashi
- 2024-05-07
Not yet recruiting
- "Real world treatment practice, effectiveness, and safety of nivolumab combination with chemotherapy as a neoadjuvant therapy for resectable NSCLC patients in Japan, an observational study"
- Resectable Non-Small Cell Lung Cancer
- Matsumoto Hiroki
- 2024-05-07
Not yet recruiting
- [M23-703] A Study to Assess Adverse Events and Change in Disease Activity from Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants with Active Ulcerative Colitis
- Ulcerative Colitis
- Otani Tetsuya
- 2024-05-07
Not yet recruiting
- A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the treatment of idiopathic pulmonary fibrosis
- idiopathic pulmonary fibrosis
- Kanmuri Kazuhiro
- 2024-05-07
Not yet recruiting
- A study of treatment of peripheral neuropathy with MSC-CM
- Peripheral neuropathy
- Kimura Shin
- 2024-05-07
Not yet recruiting
- Adjuvant therapy in pathological stage IA2-IIA EGFR-mutated NSCLC: a multicenter prospective observational study
- non-small cell lung cancer(non-squamous cell cancer)
- National Cancer Center
- 2024-05-07
Not yet recruiting
- Assessment of the educational effectiveness of a video-sharing system for remote endoscopists
- Pancreato-biliary disease, infectious colitis,Inflammatory bowel disease including disease to be differentiated
- Asahikawa Medical University
- 2024-05-07
Not yet recruiting
- Drug Use-Results Survey of PIASKY for Injection 340mg (All-Patient Surveillance) -Paroxysmal nocturnal hemoglobinuria-
- Paroxysmal nocturnal hemoglobinuria
- Chugai Pharmaceutical Co. Ltd.
- 2024-05-07
Not yet recruiting
- Multicenter retrospective study of the Efficacy of Adjuvant Immunotherapy after Radical therapy (Surgery or Radiotherapy) for Urothelial Carcinoma (Michinoku Study 1015)
- Bladder cancer
- Hirosaki University
- 2024-05-07
Not yet recruiting
- Randomized phase III trial in MMR deficient endometrial cancer patients comparing chemotherapy alone versus Dostarlimab in first line advanced/metastatic setting: DOMENICA STUDY
- endometrial adenocarcinoma
- Hasegawa Kosei
- 2024-05-07